Used as a reversible inhibitor of monoamine oxidase A (MAO-A), minaprine dihydrochloride has been investigated for its potential in treating depressive disorders. It helps increase the levels of neurotransmitters like serotonin, norepinephrine, and dopamine in the brain by preventing their breakdown, which may improve mood and emotional state. Due to its selectivity and reversibility, it offers a potentially safer profile compared to older, irreversible MAO inhibitors, with fewer dietary restrictions and reduced risk of hypertensive crises. Research has also explored its anxiolytic properties, suggesting possible use in anxiety-related conditions. However, its clinical use remains limited and it is not widely available in most countries.